|
| |
| | Medical Acupuncture Online Journal, Volume 14 #1, Article 2 |
 | | For 10 patients, needles were inserted 5 cm from the midline, to a depth of 1.25 cm, at the levels of the vertebrae above and below the dermatome of the pain area. |  | | Wu et al57 reported that daily microwave acupuncture to SP 10 and BL 17 was effective for raising the leukocyte count of patients receiving chemotherapy although they did not have a control group in their study. |  | | During the final 10 days of treatment, analgesia (complete or partial pain relief) was the same in all groups (approximately 95% immediate and 80% long-term effects) although the percentage of patients who experienced complete long-term pain relief was significantly higher in the 2 acupuncture groups (approximately 50%) than in the drug treatment group (34%). |
|
http://www.medicalacupuncture.org/aama_marf/journal/vol14_1/article2.html
(319 words)
|
|
| |
| | RM-10 Immune System Food |
 | | 12.) A 57 year old obese female with bilateral knee pain and candidiasis, experienced rapid improvement with the use of RM- 10 in her systemic yeast infection, and modest improvement in her knee pain. |  | | His cholesterol dropped 15 percent and triglycerides by 20 percent within four weeks. |  | | These interleukins are anticancer cytokines that are secreted by activated macrophages. |
|
http://www.crohns-disease-probiotics.com/RM-10.html
(319 words)
|
|
| |
| | Cancer: Gene Therapies, Stem Cells, Telomeres, And Cytokines - Abstracts : Online Reference For Health Concerns |
 | | Interleukins (IL) are a heterogeneous class of cytokines involved in activation of T lymphocytes (IL-1, 2, 4, 6 and 7), <<b>bb>>B<b>bb>> lymphocytes (IL-1, 2, 4, 5, 6 and 7), and macrophages (IL-1 and 4), and hematopoiesis (IL-1, 2, 3, 4, 5, 6 and 7), acting either by themselves, or as co-stimulator factors. |  | | Our previous study showed that high-grade astrocytomas often expressed high <<b>bb>>interleukin<b>bb>> (IL)-1beta production. |  | | <<b>bb>>Interleukin<b>bb>> (IL) -6 and IL-8 are cytokines that have been shown to play a role in several pancreatic diseases, including acute pancreatitis, chronic pancreatitis, and pancreatic adenocarcinoma. |
|
http://www.lef.org/protocols/abstracts/abstr-150.html
(319 words)
|
|
| |
| | CancerGuide: Nutritional Supplements and <<b>bb>>Interleukin<b>bb>>-2 |
 | | Marcus SL, Petrylak DP, Dutcher JP, Paietta E, Ciobanu N, Strauman J, Wiernik PH, Hutner SH, Frank O, Baker H. Hypovitaminosis C in patients treated with high-dose <<b>bb>>interleukin<b>bb>> 2 and lymphokine-activated killer cells. |  | | Marcus SL, Dutcher JP, Paietta E, Ciobanu N, Strauman J, Wiernik PH, Hutner SH, Frank O, Baker H. Severe hypovitaminosis C occurring as the result of adoptive immunotherapy with high-dose <<b>bb>>interleukin<b>bb>> 2 and lymphokine-activated killer cells. |  | | Effects of <<b>bb>>interleukin<b>bb>> 2 therapy on lymphocyte magnesium levels. |
|
http://www.cancerguide.org/rcc_il2supplements.html
(1470 words)
|
|
| |
| | Thiourea (CICADS 49, 2003) |
 | | Adult and sexually immature Sprague-Dawley rats were given Evans-Blue dye intravenously at 60 mg/kg body weight, followed by 10 or 100 mg thiourea/kg body weight, and sacrificed after 2 h. |  | | The concentration of 2.0 mg/ml proved to be ineffective in this regard. |  | | Thiourea was administered to Sprague-Dawley rats (10 per sex per dose group) at concentrations of 0, 0.02, 0.1, 0.5, or 2.5 mg/litre (0, 0.0028, 0.014, 0.070, or 0.350 mg/kg body weight per day) in the drinking-water for 13 weeks (Hazleton, 1987). |
|
http://www.inchem.org/documents/cicads/cicads/cicad49.htm
(6319 words)
|
|
| |
| | <<b>bb>>Interleukin<b>bb>> |
 | | Materials and Methods: Sixty-one CHC patients who were treated by fixed protocol of IFN therapy (IFN [alpha] 9-10 mega U/day for 2 weeks followed by 3 times/week for 22 weeks) and showed similar clinical activities were carefully chosen from 542 IFN-treated CHC and enrolled in this study. |  | | The aim of this study was determine the immunoregulatory functions of <<b>bb>>Interleukin<b>bb>> 12 (IL-12) with regard to local cytokine production in human liver. |  | | Th1 (<<b>bb>>interleukin<b>bb>> (IL)-2) and Th2 (IL-6) cytokines and monokines (IL-1 =DF, IL-1 receptor antagonist (RA)) were studied during IFN therapy. |
|
http://www.hepatitis-c.de/interleu.htm
(1158 words)
|
|
| |
| | Proceedings of the Oklahoma Academy of Science |
 | | Of the many procedures available, adherence to nylon wool columns has been used most frequently, with varying degrees of success, to separate unpurified lymphocyte preparations into T-cell (nonadherent) and <<b>bb>>B<b>bb>>-cell (adherent) subpopulations in laboratory mice (2) and rats (3), chickens (4), sheep (5), and humans (6). |  | | 2) in the nonadherent subpopulation, indicating this subtype is adhering to the nylon wool. |  | | 2), indicates that the nonadherent subpopulation is enriched in PNA+ splenocytes. |
|
http://digital.library.okstate.edu/OAS/oas_htm_files/v75/p31_37nf.html
(2739 words)
|
|
| |
| | Particle Diameter Influences Adhesion under Flow -- Patil et al. 80 (4): 1733 -- Biophysical Journal |
 | | In certain experiments, the P-selectin-coated surface was treated with mAbs to P-selectin (10 µg/ml) 15 min prior to the adhesion |  | | ( C) BSA microspheres were allowed to settle onto P-selectin under no flow conditions for 10 min. |  | | Immediately after reinitiation of flow, the number of 19.ek.Fc microspheres remaining bound to the surface was determined. |
|
http://www.biophysj.org/cgi/content/full/80/4/1733
(2739 words)
|
|
| |
| | IL2 - <<b>bb>>Interleukin<b>bb>> 2 - aka: TCGF - Cancer GeneticsWeb |
 | | Recombinant <<b>bb>>interleukin<b>bb>>-2-based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. |  | | Medline Search: <<b>bb>>interleukin<b>bb>> 2 AND cancer AND gene therapy (PubMed) |  | | <<b>bb>>Interleukin<b>bb>> 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I study. |
|
http://www.cancerindex.org/geneweb/IL2.htm
(457 words)
|
|
| |
| | Targeted Anti-<<b>bb>>Interleukin<b>bb>>-6 Monoclonal Antibody Therapy for Cancer: A Review of the Rationale and Clinical Evidence -- Trikha et al. 9 (13): 4653 -- Clinical Cancer Research |
 | | Badache A., Hynes N. <<b>bb>>Interleukin<b>bb>> 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. |  | | Bataille R., Jourdan M., Zhang X. G., Klein <<b>bb>>B<b>bb>>. Serum levels of <<b>bb>>interleukin<b>bb>> 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. |  | | Novick D., Shulman L. M., Chen L., Revel M. Enhancement of <<b>bb>>interleukin<b>bb>> 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody. |
|
http://clincancerres.aacrjournals.org/cgi/content/full/9/13/4653
(8622 words)
|
|
|